On March 3rd, Mr. Miguel Faustino, President of Thermo Fisher Scientific China, along with Ms. Shao Hong, Vice President of Commercial Operations for the China Life Sciences Division (BID), and a team of technical experts, visited DALTONbio Bio upon invitation. Dr. Benjamin Hua, President and Founder of DALTONbio, and Mr. Ying Jianjun, Operations Director and Representative of the Management, warmly welcomed the Thermo Fisher team. Both parties engaged in an open discussion on key topics of mutual interest, including the current landscape, challenges, opportunities, and future prospects of the biotechnology industry both domestically and globally.
Mr. Miguel Faustino expressed that DALTONbio is one of Thermo Fisher's key customers in China, utilizing globally leading technologies in research and development, production, and quality control. This demonstrates DALTONbio’s commitment to the quality of in vitro diagnostic products, which aligns perfectly with Thermo Fisher’s mission—"to enable our customers to make the world healthier, cleaner, and safer." He was particularly impressed by DALTONbio's outstanding achievements in cervical cancer prevention and control in China, both in terms of social contribution and commercial success. He hopes to achieve a mutually beneficial future through deeper and long-term collaboration.
Dr. Benjamin Hua first shared the journey of DALTONbio in developing, commercializing, and promoting its high-precision HPV detection technology. Large-scale, multi-center, prospective clinical studies have confirmed that this technology can be compliantly applied for cervical cancer screening in healthy populations, making it the world's first platform to obtain the "Three Primary Screening" certification. He also highlighted DALTONbio’s relentless pursuit of product quality, as evidenced by its ISO 13485 certification and multiple international certifications, including CE-IVDR, with ongoing efforts to expand collaborations to benefit women worldwide. Lastly, he introduced Hangzhou as one of China's leading cities in the biopharmaceutical industry, where local IVD (In Vitro Diagnostics) professionals embrace advanced technological concepts, customer-centric service approaches, and efficient execution capabilities. He believes that with Thermo Fisher—a global leader in enabling scientific progress—there will be broader opportunities for growth.
Following this, Thermo Fisher’s technical expert team provided insights into the latest advancements in the global life sciences field and introduced comprehensive technology solutions, engaging in professional exchanges with the DALTONbio team. Both parties agreed to hold regular meetings to enhance mutual understanding, actively explore collaboration opportunities, and seize new opportunities together.
